These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 15287778)
1. 7-substituted 2-azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn-and anti-isoepiboxidine. Malpass JR; White R J Org Chem; 2004 Aug; 69(16):5328-34. PubMed ID: 15287778 [TBL] [Abstract][Full Text] [Related]
2. Approaches to syn-7-substituted 2-azanorbornanes as potential nicotinic agonists; synthesis of syn- and anti-isoepibatidine. Malpass JR; Handa S; White R Org Lett; 2005 Jun; 7(13):2759-62. PubMed ID: 15957940 [TBL] [Abstract][Full Text] [Related]
3. Aza-Prins-pinacol approach to 7-azabicyclo[2.2.1]heptanes: syntheses of (+/-)-epibatidine and (+/-)-epiboxidine. Armstrong A; Bhonoah Y; Shanahan SE J Org Chem; 2007 Oct; 72(21):8019-24. PubMed ID: 17867705 [TBL] [Abstract][Full Text] [Related]
4. Modification of 1-substituents in the 2-azabicyclo[2.1.1]hexane ring system; approaches to potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives. Malpass JR; Patel AB; Davies JW; Fulford SY J Org Chem; 2003 Nov; 68(24):9348-55. PubMed ID: 14629156 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues. Carroll FI; Lee JR; Navarro HA; Ma W; Brieaddy LE; Abraham P; Damaj MI; Martin BR J Med Chem; 2002 Oct; 45(21):4755-61. PubMed ID: 12361403 [TBL] [Abstract][Full Text] [Related]
7. Epibatidine structure-activity relationships. Carroll FI Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of azabicyclo[2.2.n]alkane systems as analogues of 3-[1-methyl-2-(S)-pyrrolidinyl- methoxy]pyridine (A-84543). Carreras J; Avenoza A; Busto JH; Peregrina JM J Org Chem; 2007 Apr; 72(8):3112-5. PubMed ID: 17371077 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine. Carroll FI; Robinson TP; Brieaddy LE; Atkinson RN; Mascarella SW; Damaj MI; Martin BR; Navarro HA J Med Chem; 2007 Dec; 50(25):6383-91. PubMed ID: 17994682 [TBL] [Abstract][Full Text] [Related]
10. exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine. Che D; Wegge T; Stubbs MT; Seitz G; Meier H; Methfessel C J Med Chem; 2001 Jan; 44(1):47-57. PubMed ID: 11141087 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes. Cheng J; Zhang C; Stevens ED; Izenwasser S; Wade D; Chen S; Paul D; Trudell ML J Med Chem; 2002 Jul; 45(14):3041-7. PubMed ID: 12086489 [TBL] [Abstract][Full Text] [Related]
12. Stereoselective syntheses of (+/-)-epibatidine analogues. Kim YH; Won DY; Oh CY; Lee KY; Lee YS; Woo NT; Park YH; Park HJ; Ham WH Arch Pharm Res; 2002 Feb; 25(1):45-8. PubMed ID: 11885690 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists. Ji J; Schrimpf MR; Sippy KB; Bunnelle WH; Li T; Anderson DJ; Faltynek C; Surowy CS; Dyhring T; Ahring PK; Meyer MD J Med Chem; 2007 Nov; 50(22):5493-508. PubMed ID: 17929796 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analogues. Carroll FI; Brieaddy LE; Navarro HA; Damaj MI; Martin BR J Med Chem; 2005 Nov; 48(23):7491-5. PubMed ID: 16279810 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and electrophysiological studies of a novel epibatidine analogue. Spang JE; Patt JT; Bertrand S; Bertrand D; Westera G; Schubiger PA J Recept Signal Transduct Res; 1999; 19(1-4):521-31. PubMed ID: 10071782 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors. Murineddu G; Murruzzu C; Curzu MM; Chelucci G; Gotti C; Gaimarri A; Legnani L; Toma L; Pinna GA Bioorg Med Chem Lett; 2008 Dec; 18(23):6147-50. PubMed ID: 18938077 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity data of some new epibatidine analogues. Seerden JP; Tulp MT; Scheeren HW; Kruse CG Bioorg Med Chem; 1998 Nov; 6(11):2103-10. PubMed ID: 9881100 [TBL] [Abstract][Full Text] [Related]
18. aza-Prins-pinacol approach to 7-azabicyclo[2.2.1]heptanes and ring expansion to [3.2.1]tropanes. Armstrong A; Shanahan SE Org Lett; 2005 Mar; 7(7):1335-8. PubMed ID: 15787500 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist. Carroll FI; Lee JR; Navarro HA; Brieaddy LE; Abraham P; Damaj MI; Martin BR J Med Chem; 2001 Nov; 44(24):4039-41. PubMed ID: 11708907 [TBL] [Abstract][Full Text] [Related]